All In Biotech

Drug Trial Radar · NCT00125554

Metyrapone as Additive Treatment in Major Depression

Double-Blind, Placebo Controlled Trial of Metyrapone as Augmenting Agent in the Treatment of Major Depression

Last checked: Nov 20, 2026Latest source record: Aug 12, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

63

Actual

Start

May 1998

Primary completion

Not stated

Study completion Jul 2001

Sponsor

Lead sponsor
Universitätsklinikum Hamburg-EppendorfAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 1, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test whether metyrapone is an effective and safe augmenting agent in the treatment of major depression.

Conditions

  • Major Depressive Disorder

Interventions

  • MetyraponeDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Two psychometric criteria defined by the number of responders and time to onset-of-action. The number of responders was considered twice after 3 and 5 weeks by defining the treatment response as a 30% and 50% reduction
  2. the course of concentrations of ACTH, cortisol, 11-deoxycortisol and DHEA.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dept. of Psychiatry and Psychotherapy, UKE

    Hamburg, Free and Hanseatic City of Hamburg, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.